Tag Archive for: docetaxel
Phase 2 Adaptive ADT and Docetaxel Trial for mCSPC
/0 Comments/in Clinical Trial, Metastatic, Phase 2/by MaxInhibition of SREBP Reinduces Docetaxel Sensitivity in Advanced Prostate Cancer
/0 Comments/in Preclinical Research/by MaxProject Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
abiraterone acetate ADC ADT AI ai in healthcare alphafold antibody-drug conjugate apalutamide artificial intelligence ATM bispecific antibody bone metastases bone metastasis BRCA cancer immunotherapy cancer treatment clinical trial clinical trials crispr darolutamide docetaxel drug repurposing drug resistance enzalutamide gut microbiome HRR immune checkpoint inhibitors immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA nanotechnology Nectin-4 oncology oncolytic virus personalized medicine prostate cancer PSMA radioligand therapy radiopharmaceuticals real-world data T-cell therapy theranostics
Latest Posts
- Phase1/2: Kesonotide For Metastatic Castration-Resistant Prostate Cancer April 19, 2025
- Phase 1 Trial: GEN1057 Bispecific-Antibody In Metastatic Solid Tumors April 19, 2025
- CD-001: A Promising Novel Dual-Targeting Immunotherapy April 19, 2025
- SDV2102: A Promising ADC That Targets PSMA Expressing Tumors April 19, 2025